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centage of patients aged 65–74 years with comorbidities was
52.9% higher than people aged 25–34 years old (p < 0.05). For
all cohorts, regardless of age, one of four patients with T2D coin-
cides with hypertension, one of ten patients with T2D coincides
with hyperlipidemia, and one of three patients with T2D coin-
cides with both hypertension and hyperlipidemia. In 2003, the
frequency of physicians’ visits for T2D patients with hyperten-
sion and hyperlipidemia was 2.3 times higher than for T2D
patients without comorbidities (p < 0.01). In terms of T2D
comorbidities, a major trigger for physicians to prescribe a drug
is the coexistence of both hypertension and hyperlipidemia.
CONCLUSIONS: The analysis of T2D incidence trends demon-
strates that developing disease management strategies for physi-
cians should include in their judgment, the fact that in a majority
of cases, patients have T2D coinciding with cardiovascular dis-
eases and hyperlipidemia.
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OBJECTIVE: The goal of this study is to evaluate physicians’
prescribing behavior based on the results of Hb1Ac tests for
patients with type-2 diabetes. METHODS: The study design was
retrospective covering the 12-month longitudinal period June,
2003 through May, 2004. We used a three-month look back
period and a three-month look forward period for the validation
of pre and post test (HbA1c) therapy. The study was based on
the analysis of electronic CMS1500 claims for 33,764 unique
patients (HIPAA compliant) and their results from the most
recent HbA1c tests. Patients’ medication was assessed through
NCPDP electronic claims utilizing NDC codes and drug classes.
Analysis included calculations of descriptive statistics and regres-
sion modeling. RESULTS: The high level of HbA1c was discov-
ered during laboratory testing where a higher percentage of
patients without medication were placed on medication. In par-
ticular, within a category of patients with HbA1c greater than
or equal to 9mg/dL, this switch occurred 32.1% more frequently
then within a category of patients with HbA1c less than 7mg/dL
(p < 0.01). For patients with HbA1c greater than or equal to 9
mg/dL, the likelihood to change an existing therapy was 64.2%
higher than for patients with HbA1c less than 7mg/dL (p < 0.01).
Also, for people with a high level of Hb1Ac, the likelihood to
switch from monotherapy to polytherapy was 1.6 times higher
than for people with a low level of testing. CONCLUSIONS: 
For patients with type-2 diabetes, a level of Hb1Ac is one of 
the important predictors of change in a physician’s prescribing
behavior. High levels of HbA1c most likely will cause a switch
from just a dietary and exercise regimens to additional medica-
tion component.
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OBJECTIVES: To examine trends of diabetes mellitus (DM)
prevalence in adults and to investigate treatment patterns and
HbA1c control according to their body mass index (BMI) clas-
siﬁcation. METHODS: This study used the Third National
Health and Nutrition Examination Survey (NHANES III for
1988–1994) and NHANES 2001–2002, representing a national
sample of the non-institutionalized civilian US population. Study
patients were identiﬁed if they were ≥20 years old, were previ-
ously diagnosed with DM by a physician or is currently using
DM therapy (insulin or a hypoglycemic agent). DM patients
were classiﬁed as normal (BMI < 25), overweight (BMI: 25–29),
or obese (BMI ≥ 30). Data were analyzed using SAS and
SUDAAN statistical software. RESULTS: The age-adjusted
prevalence of DM signiﬁcantly increased from 5.4% in
1988–1994 to 7.1% in 2001–2002 (increase of 1.7%: p < 0.05).
In 2001–2002, DM was more prevalent in overweight patients
(6.1%) and obese patients (10.5%) than in normal weight
patients (4%). These trends were similar in 1988–1994. More
DM patients (80% of overweight and 87% of obese patients)
received treatment in 2001–2002 than during 1988–1994 (70%
and 78%) (increases: p = 0.05 respectively). Patients were treated
with oral antihyperglycemics only most frequently (56%), fol-
lowed by insulin only (17%), and with both insulin and an oral
agent (9%). Overall, mean HbA1c decreased from 7.7% (57%
of DM-patients: HbA1c ≥ 7%) in 1988–1994 to 7.5% (50% of
DM-patients: HbA1c ≥ 7%) in 2001–2002 (p = 0.24). CON-
CLUSIONS: Over the past decade, DM has become more preva-
lent in US adults, more overweight and obese DM patients have
received treatment, yet 20% of overall DM patients still have not
received treatment. In 2001–2002, half of diabetic patients did
not control their HbA1c level and diabetic patients who were
obese were less likely to control their HbA1c compared to
patients who were normal weight.
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OBJECTIVES: To investigate the association between a lower
A1c (a measure of better diabetes control) and multiple health
system and individual variables in a Latino population.
METHODS: Data were obtained from the Los Angeles Latino
Eye Study (LALES) and included 6980 participants who were
>40 years old. Subjects with a physician diagnosis and those
without were stratiﬁed and compared. Continuous variables
were summarized using means, standard deviations and T-tests.
Categorical variables were summarized using frequency tables
and Chi-square tests. Multivariate linear regression was per-
formed on subjects with diabetes. P-value less than 0.05 were
considered statistically signiﬁcant. RESULTS: There were 1095
subjects with DM resulting in a prevalence of 18%, 73.0% of
subjects were married or living with their partner, 43.4% of 
subjects were males, 65.9% of subjects had insurance coverage,
and 3.8% of the subjects without a diagnosis had A1c values
that were above the diabetic goal, indicating probable diabetes
disease. Diabetics were older than non-diabetics (57.8 vs. 53.9;
p < 0.0001), insured (73.9% vs. 64.2%; p < 0.0001) and had a
higher percentage of individuals with a household income less
than $20,000 (55.8% vs. 49.6%; p = 0.0002). In total, 57.4%
of diabetics were using oral anti-diabetic medication alone, 5.9%
were using insulin alone, 3.6% were using diet alone and 15.3%
were using a combination of oral medication and insulin. Mul-
tivariate linear regression analysis (R2 = 0.1225, p < 0.0001)
showed that being older, single, insured, male and a lower
income was associated with a lower A1c. Also fewer disease
years, higher BMI, on diet vs. combination treatment were asso-
ciated with a lower A1c. How much the subjects have adopted
the American culture, expressed as an acculturation score, was
not signiﬁcantly associated with A1c. CONCLUSIONS: Though
this study did not measure severity of disease and medication
